Dr Simon Tucker

Dr Simon Tucker was formerly Vice President of Research at Biota Pharmaceuticals (now Vaxart), where he was responsible for their entire intellectual property and research portfolio and oversaw the development of the now FDA approved influenza drug Relenza, one of only three anti-virals for influenza.

He brings decades of experience in pharmaceutical research and development and management as CEO of both Jumpstart Fertility Inc. and Continuum Biosciences Inc.

He previously worked at GD Searle, USA, helping make key discoveries leading to the development of a treatment for HIV infection.